Angina Global Market Report 2024

Description

Angina, also referred to as angina pectoris, presents as chest pain or discomfort caused by reduced blood flow to the heart muscle, typically due to blockages or narrowing of coronary arteries from atherosclerosis.

The primary types of angina include angina pectoris, unstable angina, Prinzmetal angina, and others. Angina pectoris, associated with coronary heart disease, results in chest pain or discomfort due to inadequate blood supply to the heart, often caused by arterial blockages. Treatment options range from lifestyle adjustments and medications to procedures such as angioplasty, stenting, and coronary bypass surgery. Commonly prescribed medications include beta-blockers, nitrates, calcium channel blockers, and angiotensin-converting enzyme inhibitors, utilized across various healthcare settings such as clinics and hospitals.

The angina market research report is one of a series of new reports from The Business Research Company that provides angina market statistics, including angina industry global market size, regional shares, competitors with an angina market share, detailed angina market segments, market trends, and opportunities, and any further data you may need to thrive in the angina industry. This angina market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The angina market size has grown strongly in recent years. It will grow from $10.11 billion in 2023 to $10.71 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. In the historical period, growth can be explained by factors such as the rising prevalence of coronary heart disease, greater usage of vasodilators, increased incidence of myocardial ischemia, enhanced diagnostic capabilities, and expanded utilization of imaging techniques.

The angina market size is expected to see strong growth in the next few years. It will grow to $13.61 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period is anticipated due to the increasing prevalence of chronic angina pectoris, rising numbers of drug approvals and clinical research activities, growing demand from retail pharmacies, heightened awareness about cardiovascular health, and escalating demand for medications. Key trends expected in the forecast period include advancements in early diagnostic technologies, developments in angioplasty and stenting procedures, innovations in gene therapy approaches, increasing demand for coronary stents, and advancements in treatments for coronary artery disease.

The anticipated increase in coronary artery disease cases is set to drive growth in the angina market. Coronary artery disease (CAD), also known as coronary heart disease (CHD) or ischemic heart disease (IHD), involves the narrowing or blockage of coronary arteries, critical for supplying blood, oxygen, and nutrients to the heart muscle. Lifestyle changes, environmental factors, and genetic predispositions contribute to the rising prevalence of CAD. Angina serves as a pivotal indicator for identifying and assessing CAD prevalence, guiding medical evaluations, risk stratification, treatment decisions, and public health strategies. For instance, the American Heart Association reported a rise in adults living with CAD in the U.S. from 18.2 million in 2021 to approximately 19.3 million in January 2023, underscoring the driving force behind the angina market's expansion.

Leading firms in the angina market are focusing on developing innovative medications such as metoprolol tartrate tablets to enhance treatment efficacy for CAD and related conditions. Metoprolol tartrate tablets, a widely used cardiovascular medication, target various conditions such as angina, hypertension, and heart failure. For example, Zydus received FDA approval in April 2023 to produce generic versions of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg, bolstering treatment options for cardiovascular ailments and supporting patient outcomes.

In March 2024, Novo Nordisk acquired Cardior Pharmaceuticals for $1.10 billion (€1.025 billion), aiming to fortify its cardiovascular therapeutic pipeline. This acquisition integrates Cardior's RNA-based therapeutics, notably CDR132L, currently in Phase II clinical trials for heart failure treatment, thereby expanding Novo Nordisk's capabilities in managing cardiovascular diseases. Cardior Pharmaceuticals, headquartered in Germany, specializes in angiotensin-converting enzyme inhibitors, contributing further to Novo Nordisk's strategic expansion in cardiovascular care.

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee's Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

North America was the largest region in the angina market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the angina market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The angina market consists of revenues earned by entities by providing treatments for stable angina, and microvascular angina. The market value includes the value of related goods sold by the service provider or included within the service offering. The angina market also includes sales of anticoagulants and statins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Angina Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on angina market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for angina ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The angina market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Angina Pectoris; Unstable Angina; Prinzmetal Angina; Other Types
2) By Treatment: Lifestyle Changes; Medications; Angioplasty And Stenting; Coronary Bypass Surgery; Other Treatments
3) By Drug Class: Beta Blockers; Nitrates And Calcium Channel Blockers; Angiotensin-Converting Enzyme Inhibitors; Other Drug Classes
4) By Application: Clinics; Hospitals; Other Applications
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18780

1. Executive Summary

2. Angina Market Characteristics

3. Angina Market Trends And Strategies

4. Angina Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Angina Market Size and Growth

5.1. Global Angina Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Angina Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Angina Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Angina Market Segmentation

6.1. Global Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Angina Pectoris
Unstable Angina
Prinzmetal Angina
Other Types
6.2. Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Lifestyle Changes
Medications
Angioplasty And Stenting
Coronary Bypass Surgery
Other Treatments
6.3. Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Beta Blockers
Nitrates And Calcium Channel Blockers
Angiotensin-Converting Enzyme Inhibitors
Other Drug Classes
6.4. Global Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinics
Hospitals
Other Applications

7. Angina Market Regional And Country Analysis

7.1. Global Angina Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Angina Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Angina Market

8.1. Asia-Pacific Angina Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Angina Market

9.1. China Angina Market Overview
9.2. China Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Angina Market

10.1. India Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Angina Market

11.1. Japan Angina Market Overview
11.2. Japan Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Angina Market

12.1. Australia Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Angina Market

13.1. Indonesia Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Angina Market

14.1. South Korea Angina Market Overview
14.2. South Korea Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Angina Market

15.1. Western Europe Angina Market Overview
15.2. Western Europe Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Angina Market

16.1. UK Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Angina Market

17.1. Germany Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Angina Market

18.1. France Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Angina Market

19.1. Italy Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Angina Market

20.1. Spain Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Angina Market

21.1. Eastern Europe Angina Market Overview
21.2. Eastern Europe Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Angina Market

22.1. Russia Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Angina Market

23.1. North America Angina Market Overview
23.2. North America Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Angina Market

24.1. USA Angina Market Overview
24.2. USA Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Angina Market

25.1. Canada Angina Market Overview
25.2. Canada Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Angina Market

26.1. South America Angina Market Overview
26.2. South America Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Angina Market

27.1. Brazil Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Angina Market

28.1. Middle East Angina Market Overview
28.2. Middle East Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Angina Market

29.1. Africa Angina Market Overview
29.2. Africa Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Angina Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Angina Market Competitive Landscape And Company Profiles

30.1. Angina Market Competitive Landscape
30.2. Angina Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Angina Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Novartis AG
31.3. Bristol-Myers Squibb Company
31.4. AstraZeneca PLC
31.5. Abbott laboratories
31.6. GlaxoSmithKline Plc
31.7. Eli Lilly and Company
31.8. Gilead Sciences Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Otsuka Pharmaceutical Co. Ltd.
31.11. Troikaa Pharmaceuticals Ltd
31.12. Amgen Inc.
31.13. Dr. Reddy's Laboratories
31.14. ViroMed Co. Ltd.
31.15. Lee's Pharmaceutical Holdings

32. Global Angina Market Competitive Benchmarking

33. Global Angina Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Angina Market

35. Angina Market Future Outlook and Potential Analysis

35.1 Angina Market In 2028 - Countries Offering Most New Opportunities
35.2 Angina Market In 2028 - Segments Offering Most New Opportunities
35.3 Angina Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer